Combining data on tau and Aβ levels with the results obtained using advanced brain imaging techniques comprising of computed tomography, nuclear magnetic resonance imaging, and single photon or positron emission computed tomography could enhance AD diagnosis [23]. The gene discussed is MAPT; the disease is Alzheimer disease.